Taiko Pharmaceutical Co.,Ltd.

¥260.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4574Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (6.27%)
Div yield 1.35%
ROE 8.40%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.34
PE TTM 19.00
TSR TTM (4.38%)
Mkt cap ¥13.08B
ROIC 8.39%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥325
25.07%
(14.07%)
Hold 9|6|1|11|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
5.24
5.64
5.38
5.93
8.34%
16.03%
(0.53%)
9.91%
Revenue¥B
1.106
1.124
1.160
1.228
21.15%
16.14%
15.30%
15.61%
Peers (US$83.05M)
Cap (US$)
PE
113.3M
8.148x
83.10M
13.71x
Capital
TTM
5Y
10Y
Leveragex
0.736
0.228
0.201
EBIT/Intx
1.175
1.058
0.915
Own earn%
(391.33)
(43.56)
(27.20)
Sh yield%
35.87
43.48
46.95
Owners
Insiders/Inst%
5.37
77.12
Short interest%
5.89
SBC / revenue%
3.26
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
15–23
$1 testx
—
Incr. ROIC%
3